CLEARPOINT NEURO INC. - COMMON STOCK

ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

12 Dec 2022 09:15:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present at Upcoming Investor Conferences

09 Nov 2022 09:25:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Third Quarter 2022 Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022

26 Oct 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System

23 Sep 2022 02:45:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer

20 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

19 Sep 2022 16:13:08 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Second Quarter 2022 Results

09 Aug 2022 16:15:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model

09 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs

08 Aug 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022

26 Jul 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency

21 Jul 2022 16:20:07 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

29 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Receipt of MDSAP Certification

02 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency

20 May 2022 09:29:34 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC

13 May 2022 09:25:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports First Quarter 2022 Results

11 May 2022 16:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro and Higgs Boson Health Announce Collaboration

03 May 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1

28 Apr 2022 16:05:01 By Nasdaq GlobeNewswire

ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room

27 Apr 2022 16:05:00 By Nasdaq GlobeNewswire